Mark Przybylowski

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias.

Michel Sadelain, Joseph Jurcic, Xiuyan Wang, 2011, Blood.

Production of clinical-grade plasmid DNA for human Phase I clinical trials and large animal clinical studies.

Michel Sadelain, Shirley Bartido, Isabelle Rivière, 2007, Vaccine.

Manufacturing Validation of Biologically Functional T Cells Targeted to CD19 Antigen for Autologous Adoptive Cell Therapy

Michel Sadelain, Shirley Bartido, Isabelle Rivière, 2009, Journal of immunotherapy.